We are Moving our Office!

We’re at a Turning Point—And Your Voice Matters More Than Ever

Right now, Congress is considering the Healthcare Affordability Act (H.R. 247 / S. 46)—a crucial piece of legislation that would permanently extend the enhanced ACA premium tax credits. These credits, which have helped millions of Americans afford health coverage since 2021, are set to expire at the end of 2025.

Without this bill, the consequences will be immediate and devastating—for your clients, your business, and the stability of the entire individual health insurance market.

If these enhanced credits disappear:

• Premiums will skyrocket for millions.
• Many people will lose coverage altogether.
• Clients you’ve helped find affordable plans could be priced out overnight.
• Your ability to serve them—and stay competitive—will be seriously impacted.

(more…)

Trump’s New Executive Order Aims to Slash Drug Costs by Aligning with Global Prices

May 12, 2025 – In a move to lower prescription drug costs for Americans, former President Donald Trump signed an executive order (EO) directing federal agencies to align U.S. drug prices with those paid by other nations. According to a White House fact sheet, Americans currently pay more than three times what other countries do for brand-name medications.

This marks Trump’s second major drug pricing EO in recent months. In April, he signed another order targeting high pharmaceutical costs through Medicare reforms and industry regulations. However, experts caution that these changes may take time to implement, meaning immediate relief for consumers is unlikely.

Key Provisions of the Executive Order

The latest EO outlines several aggressive measures to reduce drug prices, including:

(more…)